VAERS reports by lot

GSK Hepatitis A lot YY2R3: VAERS reports

29 VAERS reports list lot YY2R3 as a GSK Hepatitis A vaccine, received between 2022-05-20 and 2024-09-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological220%
Cardiac / Cardiovascular220%
Dermatological (non-injection-site)220%
Reproductive / Menstrual220%
Allergic / Anaphylactic110%
Musculoskeletal110%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Colorado4
Indiana3
Virginia2
Wisconsin2
Arizona1
Nevada1
Texas1
New Mexico1
Tennessee1
Wyoming1
Massachusetts1

Reports by month received

2022-051
2022-081
2022-092
2022-101
2022-113
2023-012
2023-021
2023-041
2023-051
2023-073
2023-082
2023-112
2024-012
2024-021
2024-041
2024-051
2024-062
2024-071
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.